GoodRx Holdings (GDRX) Non-Current Assets (2019 - 2025)
GoodRx Holdings (GDRX) has disclosed Non-Current Assets for 7 consecutive years, with $761.0 million as the latest value for Q4 2025.
- Quarterly Non-Current Assets rose 4.41% to $761.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.0 billion through Dec 2025, up 4.87% year-over-year, with the annual reading at $761.0 million for FY2025, 4.41% up from the prior year.
- Non-Current Assets hit $761.0 million in Q4 2025 for GoodRx Holdings, roughly flat from $760.0 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $772.8 million in Q2 2023 to a low of $387.6 million in Q1 2021.
- Historically, Non-Current Assets has averaged $673.7 million across 5 years, with a median of $718.6 million in 2023.
- Biggest five-year swings in Non-Current Assets: skyrocketed 53.89% in 2021 and later decreased 6.21% in 2024.
- Year by year, Non-Current Assets stood at $518.8 million in 2021, then soared by 32.03% to $684.9 million in 2022, then increased by 4.54% to $716.0 million in 2023, then grew by 1.79% to $728.8 million in 2024, then rose by 4.41% to $761.0 million in 2025.
- Business Quant data shows Non-Current Assets for GDRX at $761.0 million in Q4 2025, $760.0 million in Q3 2025, and $768.1 million in Q2 2025.